Balance Wealth
BSX icon

Balance Wealth’s Boston Scientific BSX Stock Holding History

Balance Wealth’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$350 Buy
+8
New +$370 ﹤0.01% 912

Other funds holding BSX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Balance Wealth's BSX Position: Q3 2026 in Review

Balance Wealth opened a new position in Boston Scientific (BSX) in Q3 2026: 8 shares worth $350. The stake represents ﹤0.01% of the portfolio and ranks #912 among its holdings.

1,259 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Balance Wealth held 8 shares of Boston Scientific worth $350 as of Q3 2026.
  • Boston Scientific was a new Balance Wealth position in Q3 2026.
  • Boston Scientific made up ﹤0.01% of Balance Wealth's portfolio in Q3 2026, its #912 holding.
  • 1,259 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Balance Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.